Prevention of Celiac Disease by Transgenic Removal of Prolamin T-cell Epitopes
通过转基因去除谷醇溶蛋白 T 细胞表位来预防乳糜泻
基本信息
- 批准号:7600499
- 负责人:
- 金额:$ 20.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-02 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressAutoimmune ProcessAutoimmune ResponsesBarleyBiologicalC hordeinCeliac DiseaseCellsCerealsCharacteristicsChronicCodeCodon NucleotidesCpG IslandsCysteineCysteine ProteaseD hordeinDevelopmentDigestionDiseaseDrug Metabolic DetoxicationElastinEnzymesEpitheliumEpitopesEscherichia coliExcisionExposure toFoodGenerationsGenesGenetic TranscriptionGenomeGliadinGlutamineGlutenGoalsHLA AntigensHandHumanHypermethylationIn VitroIndividualInflammatoryIngestionInjuryIntestinal MucosaIntestinesKnock-outKnowledgeLeadLeftLifeMethylationModelingMolecularMolecular ConformationMolecular WeightMonoclonal AntibodiesMorbidity - disease rateMucous MembraneMutationOrthologous GenePainPancreasPatientsPeptide HydrolasesPeptidesPerfusionPlantsPopulationPrevalencePreventionProlamineProlineProteinsProteolysisRattusReactionRecombinantsResearchResistanceRye cerealSeedsSiteSmall IntestinesSprueStomachStructural GenesStructureSymptomsSystemT-LymphocyteT-Lymphocyte EpitopesTestingTissuesTranscriptional RegulationTransgenic OrganismsVacuoleWheatbrush border membranecellular microvillusearly childhoodeffective therapygluteninin vivointerestmicrobialmortalitymutantplant prolamin proteinpreventprolyl oligopeptidasepromoterresearch studyresilin
项目摘要
DESCRIPTION (provided by applicant): Celiac disease is the most common food-sensitive enteropathological condition in humans and caused by an autoimmune reaction against wheat, barley and rye prolamins. In human leukocyte antigen (HLA) DQ2 (or DQ8)-positive individuals exposure to gluten can lead to a painful chronic erasure of the microvilli of the epithelium in the intestine and to a permanent intolerance of dietary gluten. It is commonly detected in early childhood in cases with severe symptoms. In many patients symptoms arise only later in life and, if untreated, it is associated with increased morbidity and mortality. Despite its prevalence in most populations (up to 1 in 200), the only effective therapy is strict dietary abstinence from these food grains. Recent research has established that the autoimmune response results from the resistance to digestion of certain prolamine/glutamine rich peptides of the prolamins by gastric, pancreatic and brush-border membrane proteases. These peptides are taken up through the intestinal mucosa and initiate the autoimmune response. In this proposal we wish to address the following testable hypotheses for removal of the prolamin T-cell stimulating epitopes in barley and wheat. 1) The fully viable barley mutation lys3a prevents transcription of all prolamin genes requiring de-methylation of their promoters in the developing endosperm except of the single gene with a CpG island encoding the High Molecular (HMW) D-hordein. This prolamin is highly homologous to the wheat HMW prolamins that are responsible for baking quality. We ask the question if we can exploit this mutation to obtain barley grain that provides celiac safe food products. 2) The close evolutionary relationship of barley and wheat makes it likely that the two cereals employ the same transcriptional control system for the synthesis of the storage proteins in the grain. We want to test this by selecting ortholog mutations of lys3a in wheat and ask the question if it prevents the transcription of the gliadin genes but not the 6 HMW genes present in hexaploid wheat. 3) Proline/glutamine rich peptides containing T-cell stimulating epitopes can be detoxified by prolyl endopeptidases and the barley cysteine endoprotease EP-B in vitro and in vivo with rat intestinal perfusion experiments. We want to test if it is possible to synthesize these enzymes in transgenic barley and wheat during endosperm development, target the enzymes into the storage vacuoles and detoxify the prolamins during grain development.Celiac disease or sprue is the most common food-sensitive enteropathy in humans resulting from chronic inflammatory injury to the mucosa of the small intestine after ingestion of proline- and glutamine-rich prolamins present in wheat gluten as well as in barley and rye grain storage proteins. To date the only effective treatment of this debilitating disease is life-long strict abstinence from the staple food grains. The goal of this research is to eliminate the celiac causing epitopes of prolamins by exploiting the cell biological features of prolamin synthesis in the endosperm of barley and wheat.
描述(由申请人提供):乳糜泻是人类最常见的食物敏感的肠道病理状况,由对小麦、大麦和黑麦蛋白的自身免疫反应引起。在人白细胞抗原(HLA) DQ2(或DQ8)阳性的个体中,暴露于谷蛋白可导致肠上皮微绒毛的慢性清除和对饮食谷蛋白的永久不耐受。通常在儿童早期发现有严重症状的病例。在许多患者中,症状仅在生命后期才出现,如果不加以治疗,则与发病率和死亡率增加有关。尽管它在大多数人群中普遍存在(高达1 / 200),但唯一有效的治疗方法是严格禁食这些食物。最近的研究表明,自身免疫反应是由于胃、胰腺和刷缘膜蛋白酶对某些富含脯胺/谷氨酰胺的脯胺肽的消化产生抵抗。这些肽通过肠黏膜吸收并启动自身免疫反应。在这一建议中,我们希望解决以下可测试的假设,以去除大麦和小麦中的蛋白蛋白t细胞刺激表位。1)在发育中的胚乳中,完全活的大麦突变lys3a阻止了所有需要启动子去甲基化的prolamin基因的转录,除了编码HMW - D-hordein的CpG岛基因。这种蛋白与小麦HMW蛋白高度同源,后者负责烘焙质量。我们的问题是,我们是否可以利用这种突变来获得大麦谷物,提供乳糜泻安全的食品。2)大麦和小麦的密切进化关系使得这两种谷物可能采用相同的转录控制系统来合成谷物中的贮藏蛋白。我们想通过选择小麦中lys3a的同源突变来验证这一点,并询问它是否阻止麦胶蛋白基因的转录,而不是六倍体小麦中存在的6个HMW基因的转录。3)在体外和体内大鼠肠道灌注实验中,含有t细胞刺激表位的富含脯氨酸/谷氨酰胺的肽可被脯氨酸内肽酶和大麦半胱氨酸内蛋白酶EP-B解毒。我们想测试是否有可能在转基因大麦和小麦胚乳发育期间合成这些酶,并在籽粒发育期间将这些酶靶向到储存液泡中并解毒蛋白。乳糜泻是人类最常见的食物敏感性肠病,是由于摄入了小麦麸质以及大麦和黑麦谷物储存蛋白中富含脯氨酸和谷氨酰胺的脯氨酸后,小肠黏膜受到慢性炎症损伤而引起的。迄今为止,治疗这种使人衰弱的疾病的唯一有效方法是终生严格禁食主食谷物。本研究的目的是利用大麦和小麦胚乳中蛋白合成的细胞生物学特性,消除引起乳糜泻的蛋白表位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DITER H VON WETTSTEIN其他文献
DITER H VON WETTSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DITER H VON WETTSTEIN', 18)}}的其他基金
Prevention of Celiac Disease by Transgenic Removal of Prolamin T-cell Epitopes
通过转基因去除谷醇溶蛋白 T 细胞表位来预防乳糜泻
- 批准号:
7763944 - 财政年份:2008
- 资助金额:
$ 20.22万 - 项目类别:
Prevention of Celiac Disease by Transgenic Removal of Prolamin T-cell Epitopes
通过转基因去除谷醇溶蛋白 T 细胞表位来预防乳糜泻
- 批准号:
8022960 - 财政年份:2008
- 资助金额:
$ 20.22万 - 项目类别:
Prevention of Celiac Disease by Transgenic Removal of Prolamin T-cell Epitopes
通过转基因去除谷醇溶蛋白 T 细胞表位来预防乳糜泻
- 批准号:
7388495 - 财政年份:2008
- 资助金额:
$ 20.22万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20.22万 - 项目类别:
Research Grant














{{item.name}}会员




